Human iPSC-Derived Dorsal Root Ganglion Organoid Modeling of Chemotherapy-Induced Peripheral Neuropathy
Cells · 19.04.2026 · 15 (8) · 724
DOI: 10.3390/cells15080724 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, online erschienen am 19.04.2026. Verfasst von Sybil C L Hrstka und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA. Hauptthemen laut MEDLINE: Ganglia, Spinal, Induced Pluripotent Stem Cells, Peripheral Nervous System Diseases, Organoids. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Chemotherapy-induced peripheral neuropathy (CIPN) is a dose-limiting toxicity affecting 30–40% of patients treated with neurotoxic chemotherapy. Sensory symptoms arise from injury to dorsal root ganglion (DRG) neurons and their axons; yet, the underlying mechanisms remain incompletely understood. While human induced pluripotent stem cell (iPSC)-derived sensory neuron (iSN) monolayers have provided mechanistic insight, they lack the three-dimensional architecture and cellular heterogeneity of native DRG tissue. Here, we generated human iPSC-derived DRG organoids (iDRGOs) containing mixed neuronal and peripheral glial populations and established a quantitative neurite outgrowth assay to model chemotherapy-induced neurotoxicity in a 3D context. iDRGOs from three healthy donors were exposed to bortezomib, vincristine, or paclitaxel. All three drugs caused dose-dependent neurite outgrowth impairment without significant short-term changes in organoid size, consistent with early axonal injury. Vincristine reduced MAP2 levels when normalized to total protein, whereas bortezomib and paclitaxel showed divergent microtubule-associated responses compared to monolayer cultures. The developmental stage significantly influenced the baseline neurite outgrowth, highlighting the need for age standardization. These results establish iDRGOs as a physiologically relevant human platform that complements monolayer models for mechanistic studies and therapeutic screening in CIPN.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA.
ORCID-Profile: Sybil C L Hrstka, Nathan P Staff
Förderung
- NCI NIH HHS
- National Cancer Institute
Zitieren
APA
Hrstka, S. C. L., Jahnke, M., Meng-Lin, K., Lindorfer, S., Noma, H., Hrstka, R. F., & Staff, N. P. (2026). Human iPSC-Derived Dorsal Root Ganglion Organoid Modeling of Chemotherapy-Induced Peripheral Neuropathy. Cells, 15(8), 724. https://doi.org/10.3390/cells15080724
Vancouver
Hrstka SCL, Jahnke M, Meng-Lin K, Lindorfer S, Noma H, Hrstka RF, et al. Human iPSC-Derived Dorsal Root Ganglion Organoid Modeling of Chemotherapy-Induced Peripheral Neuropathy. Cells. 2026;15(8):724. doi:10.3390/cells15080724
BibTeX
@article{Hrstka2026,
author = {Hrstka, Sybil C L and Jahnke, Maya and Meng-Lin, Kylie and Lindorfer, Sarah and Noma, Henry and Hrstka, Ronald F and Staff, Nathan P},
title = {Human iPSC-Derived Dorsal Root Ganglion Organoid Modeling of Chemotherapy-Induced Peripheral Neuropathy},
journal = {Cells},
year = {2026},
volume = {15},
number = {8},
pages = {724},
doi = {10.3390/cells15080724}
}
EUVIMED